13F manager/ONC/

Baillie Gifford exit BeOne Medicines Ltd.

Baillie Gifford exit $-583.1M of disclosed value in BeOne Medicines Ltd..

Signal
Investor Move
Action
Exit
Capital
$-583.1M disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence